Phase 3 Peripheral Neuropathy Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are 18 years of age or older
- People who have given their consent to take part in the study
- People who are covered by a social security or health insurance plan
- People who have been diagnosed with pudendal neuralgia (a type of chronic pelvic nerve pain), confirmed using a specific set of diagnostic criteria known as the "modified Nantes criteria"
- People whose MRI scan results are normal or do not show any condition that would explain their pain
- People whose pain has not responded well enough to medication — specifically, where at least one anti-seizure medication and one antidepressant (both used here for nerve pain) have been tried at the highest tolerable dose without reducing pain sufficiently, or where side effects prevented the dose from being increased to the maximum allowed level
Who may not be able to join:
- People who are under a legal protection or guardianship order
- People who are pregnant or breastfeeding
- People who currently have an active general or local infection, including certain types of infections near the anal area
- People who have a known neurological condition that could explain their pain
- People who have a psychiatric condition that requires medication to manage
- People who take blood-thinning medications or have a condition affecting blood clotting
- People who have a known sensitivity or allergic reaction to lidocaine hydrochloride or other local anaesthetic medications
- People who have a condition called recurrent porphyria (a rare disorder affecting the nervous system or skin)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Comparison between the two treatment arms (lidocaine vs.saline) of the rate of patients with a decrease of at least 3 points on a visual 3 points on a visual analogue pain scale (VAS) between inclusion and
Can't join this trial?
Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.